1535204-23-9 Usage
Description
(E)-3-(hydroxy(phenyl)methylene)-6-iodoindolin-2-one is a complex chemical compound belonging to the indolin-2-one family, characterized by its unique molecular structure that includes a phenyl group, a hydroxy group, and an indolin-2-one ring with an iodine atom attached. (E)-3-(hydroxy(phenyl)methylene)-6-iodoindolin-2-one is recognized for its potential pharmaceutical properties and is of interest for its possible applications in drug development due to its distinctive structural features and potential biological activities.
Uses
Used in Pharmaceutical Industry:
(E)-3-(hydroxy(phenyl)methylene)-6-iodoindolin-2-one is used as a potential pharmaceutical agent for [application reason] due to its unique structure and potential biological activities. Further research and testing are required to fully understand its properties and potential uses in the development of new drugs.
Used in Drug Development:
In the field of drug development, (E)-3-(hydroxy(phenyl)methylene)-6-iodoindolin-2-one is used as a compound with potential applications in creating new therapeutics. Its specific role in drug development may include targeting various diseases or conditions, depending on the outcomes of ongoing research and testing.
Check Digit Verification of cas no
The CAS Registry Mumber 1535204-23-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,5,3,5,2,0 and 4 respectively; the second part has 2 digits, 2 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1535204-23:
(9*1)+(8*5)+(7*3)+(6*5)+(5*2)+(4*0)+(3*4)+(2*2)+(1*3)=129
129 % 10 = 9
So 1535204-23-9 is a valid CAS Registry Number.
1535204-23-9Relevant articles and documents
3-{3-[1 -(4-DIMETHYLAMINOMETHYL-PHENYLAMINO)-1 -PHENYL-METH-(Z)-YLIDENE]-2-OXO-2,3-DIHYDRO-1 H-INDOL-6-YLL-PROPYNOIC ACID ETHYLAMIDE AND ITS USE IN THE TREATMENT OF CANCER
-
Page/Page column 88; 89, (2014/02/15)
The present invention relates to 3-{3-[1-(4-Dimethylaminomethyl- phenylamino)-1-phenyl-meth-(Z)-ylidene]-2-oxo-2,3-dihydro-1 H- indol-6-yll-propynoic acid ethylamide having the formula (I) below, to a process for the manufacture thereof, and to the use thereof in the treatment of diseases characterized by excessive or abnormal cell proliferation.
INDOLINONE DERIVATIVES ANTICANCER COMPOUNDS
-
Page/Page column 67, (2014/02/15)
The invention describes indolinones derivatives as dual Aurora kinase / MEK inhibitors and their use in therapy.